Biogen Employees 2024

Biogen Employees

7,400

Biogen Dividend yield

Ticker

BIIB

ISIN

US09062X1037

WKN

789617

In 2024, Biogen employed 7,400 people, a 0% change from the 7,400 number of employees in the previous year.

Biogen Aktienanalyse

What does Biogen do?

Biogen Inc. is an American biotechnology company specializing in the development, manufacturing, and marketing of therapeutics for neurodegenerative diseases, autoimmune diseases, and hemophilia. The company was founded in 1978 and is a Fortune 500 company headquartered in Cambridge, Massachusetts. It employs over 7,000 employees worldwide. The origins of Biogen can be traced back to its founding by Charles Weissmann, a Swiss biology professor, and American entrepreneurs Walter Gilbert and Phillip Sharp. The company initially focused on the development of interferon, a protein that protects the body against viruses. However, in the late 1980s, Biogen shifted its research and development efforts towards neurodegenerative diseases. Biogen's business model is based on the discovery and development of new and unique treatments for serious diseases. Through research, the discovery of new compounds, as well as acquisitions and partnerships with other companies, Biogen continually expands its product pipeline. The company also has a strong presence in the global market, selling its products in over 90 countries worldwide. Biogen has sought to expand into multiple areas of the biopharmaceutical industry. The company is divided into three main business areas: neurology, immunology, and hemophilia. In the neurology field, Biogen is a leading provider of drugs for the treatment of severe diseases such as multiple sclerosis, spinal muscular atrophy, and Alzheimer's. The company has developed several innovative therapeutics that can either slow down or even halt the progression of these diseases. One example is the drug Aduhelm®, which recently gained approval from the US Food and Drug Administration (FDA) for the treatment of Alzheimer's and garnered worldwide attention. In the immunology field, Biogen offers medications for the treatment of autoimmune diseases such as rheumatoid arthritis and psoriasis. Biogen is also a major provider of biosimilars, which are replicas of biopharmaceutical drugs developed and manufactured by other companies. Biosimilars can help reduce the cost of patient treatment, particularly in countries with limited healthcare resources. In the hemophilia field, Biogen's offerings include a range of products and services specifically developed for patients with hemophilia. These include clotting factor preparations for the treatment of bleeding, novel clotting factors, and specialized clotting tests. Biogen also invests significantly in the research of new technologies and platforms. The company has formed partnerships with other leading biotech companies such as Ionis Pharmaceuticals and Sangamo Therapeutics to develop innovative technologies like antisense oligonucleotides, genome editing, and gene silencing. Biogen is also a founding member of BioNTech, a German biotechnology company known for its development of mRNA-based vaccines for cancer and infectious diseases. Overall, Biogen has an impressive track record in the development of innovative therapeutics for complex diseases. The company has a strong presence in the global market and aims to expand its product pipeline through research and partnerships. With its high commitment to innovation, Biogen is well-positioned to play a significant role in the biopharmaceutical industry in the future. Biogen ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Biogen revenue by segment

In the annual report of the Biogen share (US09062X1037, 789617, BIIB), it breaks down its revenues into 3 segments: 1. Product, 2. Other, 3. Therapeutics. The Biogen stock (WKN: 789617, ISIN: US09062X1037, Ticker Symbol: BIIB) is a leading investment for investors interested in participating in the Health Care sector.

Employees Details

Examining Biogen's Employee Base

Biogen's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Biogen's operational capacity and future potential.

Year-to-Year Comparison

Assessing Biogen's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Biogen's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Biogen’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Biogen Stock

How many employees does Biogen have this year?

Biogen has 7,400 undefined employees this year.

How many employees did Biogen have compared to the previous year?

Compared to the previous year, Biogen had 0% more employees.

What impact did the number of employees have on the company Biogen?

The number of employees has a direct impact on the efficiency and productivity of Biogen. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Biogen?

The number of employees can also have an impact on investors of Biogen, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Biogen affect the company?

An increase in equity of Biogen can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Biogen's equity affect the company?

A reduction in equity of Biogen can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Biogen?

Some factors that can influence the equity of Biogen include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Biogen so important for investors?

The equity of Biogen is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Biogen influence the company?

The number of employees at Biogen can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Biogen evolved in recent years?

In recent years, the number of employees at Biogen has changed by 0.

How many employees does Biogen currently have?

Biogen currently has 7,400 undefined employees.

Why is the number of employees important for investors of Biogen?

The number of employees is important for investors of Biogen as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Biogen take to change the number of employees?

To change the number of employees, Biogen can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Biogen pay?

Over the past 12 months, Biogen paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Biogen is expected to pay a dividend of 0 USD.

What is the dividend yield of Biogen?

The current dividend yield of Biogen is .

When does Biogen pay dividends?

Biogen pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Biogen?

Biogen paid dividends every year for the past 0 years.

What is the dividend of Biogen?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Biogen located?

Biogen is assigned to the 'Health' sector.

Wann musste ich die Aktien von Biogen kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Biogen from 3/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 3/29/2024.

When did Biogen pay the last dividend?

The last dividend was paid out on 3/29/2024.

What was the dividend of Biogen in the year 2023?

In the year 2023, Biogen distributed 0 USD as dividends.

In which currency does Biogen pay out the dividend?

The dividends of Biogen are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Biogen stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank

Andere Kennzahlen von Biogen

Our stock analysis for Biogen Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biogen Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.